2836-40-0

Usage

Uses

Used in Pharmaceutical Industry:
2-chloro-N-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide is used as a building block in the synthesis of various drugs and pharmaceutical intermediates. Its structural complexity, including the chloro and fluorobenzoyl groups, makes it a valuable component in the development of new therapeutic agents.
Used in Drug Development:
2-chloro-N-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide is studied for its potential biological activities, such as anti-inflammatory and analgesic properties. The presence of functional groups in its structure suggests that it may interact with biological targets, contributing to its potential as a molecule of interest in drug development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-chloro-N-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide is utilized for its potential to modulate biological activity through specific interactions with enzymes or receptors. Its unique structural elements position it as a candidate for further exploration and optimization in the design of novel pharmaceuticals.

InChI:InChI=1/C15H10Cl2FNO2/c16-8-14(20)19-13-6-5-9(17)7-11(13)15(21)10-3-1-2-4-12(10)18/h1-7H,8H2,(H,19,20)

Upstream product

• 79-04-9 chloroacetyl chloride 
• 784-38-3 2-amino-5-chloro-2'-fluorobenzophenone 

Downstream Products

• 2147-80-0 3,3'-bis-[4-chloro-2-(2-fluoro-benzoyl)-phenyl]-1,1'-methanediyl-bis-imidazolidin-4-one 
• 2886-65-9 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2(2H)-one 
• 2147-81-1 3-[4-chloro-2-(2-fluoro-benzoyl)-phenyl]-imidazolidin-4-one 
• 1645-32-5 7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepine-2-thione 
• 880875-76-3 C₂₀H₁₃ClFN₂O⁽¹⁺⁾*Cl^(1-) 

Relevant academic research and scientific papers

Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives

A series of 4-aryl-6-chloro-quinolin-2-ones and 5-aryl-7-chloro-1,4-benzodiazepine were synthesized and assayed for their in vitro anti-hepatitis B virus activities and cytotoxicities for the first time. Some of the tested compounds were active against HBsAg and HBeAg secretion in Hep G2.2.15 cells. Compound 5c showed IC50 of 0.074 and 0.449 mM on HBsAg and HBeAg secretions, respectively, which were 10 times higher than that of its analog 4c and led to better selective index (SI) values (SI = 23.2 and 3.4, respectively).

COMPOUNDS WHICH INCREASE APOLIPOPROTEIN A-1 PRODUCTION AND USES THEREOF IN MEDICINE

The present invention relates to compounds of formula (I), pharmaceutically acceptable salts thereof, hydrates thereof, solvates thereof, prodrugs thereof and combinations thereof: wherein X represents CH or N; Y represents CH or N; R1 represents H or C1-2alkyl; R2 represents H or C1-4alkyl; R3 represents C1-6alkyl, carbocyclyl, carbocyclylC1-4alkyl, heterocyclyl or heterocyclylC1-4alkyl, wherein any of the carbocyclyl or heterocyclyl groups are optionally substituted by one or two groups selected from: halogen, C1-6alkyl, haloC1-6alkyl, hydroxyC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy, nitro, cyano, -COH, -COOH, C1-6alkoxycarbonyl, C1-6alkylcarbonyl, -C(OH)R5R6 (wherein R5 and R6 independently represent H or C1-6alkyl), -(CH2)nNR3aR3b and -O(CH2)pNR3aR3b (wherein n represents 1, 2 or 3, p represents 2 or 3 and R3a and R3b independently represent H, C1-6alkyl or carbocyclylC1-4alkyl, or R3a and R3b together with the interconnecting atoms form a 5 or 6-membered ring which ring optionally contains one or two heteroatoms independently selected from the group consisting of O, S and N); R4 represents H, hydroxy, halo, C 1-6 alkyl, haloC1-6alkyl, hydroxyC1-6alkyl, C2-6alkenyl, C1-6alkoxy, haloC1-6alkoxy, carbocyclyl or heterocyclyl, wherein the carbocyclyl or heterocyclyl group is optionally substituted by one or two groups selected from: halogen, C1-6alkyl, haloC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy, nitro and cyano; and provided that the compound is not: 7-chloro-5-phenyl-[1,2,4]triazolo[4,3-a]quinolin-4-amine; 7-chloro-1-methyl-5-phenyl[1,2,4]triazolo[4,3-a]quinolin-4-amine; or 7-chloro-5-(2-chlorophenyl)-1-methyl-{1,2,4]triazolo[4,3-a]quinolin-4-amine. Also disclosed are pharmaceutical compositions containing the compounds and to their use in medicine. The compound exhibit increased apo-A1 production and are useful in the treatment for example a disease or condition caused by raised levels of LDL-cholesterol or by inflammation.